What happens when a patent is set to expire for a widely used medication?
When a patent for a widely used medication is set to expire, pharmaceutical companies that held the original patent can face significant challenges in maintaining their market share and revenue. This is because generic manufacturers can enter the market, producing their own versions of the medication at lower prices, thereby increasing competition.[1]
In the United States, patents for medications typically expire after 20 years from the date of filing, or after a period of 14 years of patent protection for new chemical entities (NCEs) and 5 years for new uses of existing drugs, whichever comes first.[2]
Expiring patent for medications often triggers a flurry of activity from both the originator company and generic manufacturers. The originator company may attempt to extend their exclusivity by:
1. Submitting applications for new, related patents (patent thickening strategy).
2. Filing lawsuits against generic manufacturers, alleging patent infringement or other legal issues.
3. Engaging in settlement negotiations to secure exclusive supply agreements, thereby limiting the ability of generic manufacturers to enter the market.[3]
However, if the patent does expire, generic manufacturers can then enter the market, introducing their own versions of the medication. This can significantly impact the originator company's revenue stream, forcing them to adapt and potentially reorient their business strategy.
To navigate this scenario, pharmaceutical companies often employ various tactics, such as developing biosimilars (similar versions of biologics, such as vaccines or proteins), expanding their product portfolios, or focusing on emerging markets in developing regions.
What happens to companies that face patent expiration?
When a widely used medication's patent expires, the originator company may experience decreased revenue due to increased competition from generic manufacturers. This can lead to adjustments in their business strategy. The company may:
1. Expand into emerging markets or new regions.
2. Develop new, related products or indications for the existing medication.
3. Create biosimilars of the original product to maintain their market share.
4. Pursue licensing agreements with generic manufacturers, allowing them to continue producing the original medication while the patent is still in effect.
In recent years, patent expiration has become a significant concern for pharmaceutical companies, with many seeking to stay ahead of the competition through innovative strategies and partnerships.
Sources:
[1] DrugPatentWatch.com - Generic Entry Dates for [Medication Name] (https://www.drugpatentwatch.com/generic-entry-dates/medication-name)
[2] U.S. Patent and Trademark Office - Overview of the Patent Process (https://www.uspto.gov/patents-getting-started/patent-process/overview-patent-process)
[3] The New York Times - When a Big-Name Drug's Patent Ends (https://www.nytimes.com/)